Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP372114.RAwIKW5wIeFmcoO9vpeAeY14fGa1gR8-bjsmvO_kU16sI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP372114.RAwIKW5wIeFmcoO9vpeAeY14fGa1gR8-bjsmvO_kU16sI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP372114.RAwIKW5wIeFmcoO9vpeAeY14fGa1gR8-bjsmvO_kU16sI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP372114.RAwIKW5wIeFmcoO9vpeAeY14fGa1gR8-bjsmvO_kU16sI130_provenance.
- NP372114.RAwIKW5wIeFmcoO9vpeAeY14fGa1gR8-bjsmvO_kU16sI130_assertion description "[The drug also decreased levels of phosphorylated Akt, mammalian target of Rapamycin (mTOR), and eukaryotic translation initiation factor 4E binding protein (eIF4E-BP) and lowered the cap site binding activity of eIF4E in the MCL cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP372114.RAwIKW5wIeFmcoO9vpeAeY14fGa1gR8-bjsmvO_kU16sI130_provenance.
- NP372114.RAwIKW5wIeFmcoO9vpeAeY14fGa1gR8-bjsmvO_kU16sI130_assertion evidence source_evidence_literature NP372114.RAwIKW5wIeFmcoO9vpeAeY14fGa1gR8-bjsmvO_kU16sI130_provenance.
- NP372114.RAwIKW5wIeFmcoO9vpeAeY14fGa1gR8-bjsmvO_kU16sI130_assertion SIO_000772 17606765 NP372114.RAwIKW5wIeFmcoO9vpeAeY14fGa1gR8-bjsmvO_kU16sI130_provenance.
- NP372114.RAwIKW5wIeFmcoO9vpeAeY14fGa1gR8-bjsmvO_kU16sI130_assertion wasDerivedFrom befree-20150227 NP372114.RAwIKW5wIeFmcoO9vpeAeY14fGa1gR8-bjsmvO_kU16sI130_provenance.
- NP372114.RAwIKW5wIeFmcoO9vpeAeY14fGa1gR8-bjsmvO_kU16sI130_assertion wasGeneratedBy ECO_0000203 NP372114.RAwIKW5wIeFmcoO9vpeAeY14fGa1gR8-bjsmvO_kU16sI130_provenance.
- befree-20150227 importedOn "2015-02-27" NP372114.RAwIKW5wIeFmcoO9vpeAeY14fGa1gR8-bjsmvO_kU16sI130_provenance.